Research Applications of Tavanic Sanofi
Tavanic Sanofi is a fluoroquinolone antibiotic pharmaceutical containing levofloxacin as the active research compound. This commercial formulation enables laboratory investigation of antimicrobial mechanisms, bacterial resistance development, and pharmacokinetic properties in controlled research environments. Stroid UK Shop supplies this pharmaceutical-grade compound for academic and commercial laboratory applications studying bacterial DNA gyrase inhibition and topoisomerase IV modulation pathways.
Research scientists examine this levofloxacin-containing preparation to understand fluoroquinolone mechanism of action against gram-positive and gram-negative bacterial strains in vitro. Laboratory studies investigate the compound’s ability to interfere with bacterial DNA replication through dual-target inhibition of DNA gyrase and topoisomerase IV enzymes. Microbiologists utilise Tavanic Sanofi to evaluate minimum inhibitory concentrations, bactericidal kinetics, and post-antibiotic effects across diverse bacterial isolates in research protocols.
Antimicrobial Research Specifications
The pharmaceutical preparation enables investigation of concentration-dependent bacterial killing and time-dependent pharmacodynamic parameters in laboratory bacterial culture systems. Research applications include studying efflux pump mechanisms, chromosomal mutation patterns, and plasmid-mediated resistance development when bacterial strains are exposed to varying levofloxacin concentrations. Antibiotic research compounds like Tavanic provide standardised reference materials for comparative antimicrobial efficacy studies and resistance surveillance programmes.
Advanced laboratory research examines the compound’s interaction with bacterial membrane permeability, biofilm disruption capabilities, and synergistic effects when combined with other antimicrobial agents. Pharmaceutical scientists investigate formulation stability, degradation pathways, and analytical method validation using this commercial-grade levofloxacin preparation. Research also encompasses examining quinolone structure-activity relationships and developing novel fluoroquinolone derivatives with enhanced antimicrobial profiles.
| Parameter | Specification |
|---|---|
| Active Compound | Levofloxacin |
| Pharmaceutical Class | Fluoroquinolone Antibiotic |
| Manufacturer | Sanofi |
| CAS Number | 100986-85-4 |
| Molecular Formula | C₁₈H₂₀FN₃O₄ |
| Molecular Weight | 361.37 g/mol |
| Storage Conditions | Room temperature, dry environment |
| Research Applications | Antimicrobial mechanism studies, resistance research |
Comparative studies utilise this standardised pharmaceutical preparation alongside SARM research compounds and peptide research materials in multi-disciplinary laboratory programmes examining cellular response mechanisms and molecular pathway interactions across diverse biological systems.
Laboratory Research Compliance
Tavanic Sanofi is supplied exclusively for in-vitro laboratory research and academic study purposes. This pharmaceutical-grade compound is intended for qualified research institutions and licensed laboratories investigating antimicrobial mechanisms, bacterial resistance patterns, and pharmaceutical development applications. Not approved for human consumption, therapeutic use, or clinical applications outside controlled research environments.
